Literature DB >> 20836970

[Guidelines for evidence-based Chinese medicine clinical pathway report].

Si Cheng Wang1, Jian-Ping Liu, Hui Li, He Yu.   

Abstract

Clinical pathway (CP), as a standardized approach and clinical management process for disease diagnosing and treating, is being widely used with more relevant publications reported gradually. But different forms of CP reports may prevent the evaluation and spreading of CP. The authors recommend guidelines for evidence-based Chinese medicine CP report, including 18 items which form 5 big sections, by precise item selection and rigorous expert consensus. All these items can embody the principles of Chinese medicine and comply with the requirements of the clinical practice of Chinese medicine. All above are based on synthesizing the published literature systematically and analyzing the current status in this field, also according to the characteristics of Chinese medicine and methodology requirement of evidence-based medicine.

Mesh:

Year:  2010        PMID: 20836970     DOI: 10.3736/jcim20100903

Source DB:  PubMed          Journal:  Zhong Xi Yi Jie He Xue Bao        ISSN: 1672-1977


  3 in total

1.  Translating evidence into policy in China: opportunities and challenges.

Authors:  Jiyao Wang; Xuejuan Jin
Journal:  Front Med       Date:  2011-10-02       Impact factor: 4.592

Review 2.  Exploring the methodology and application of clinical pathway in evidence-based Chinese medicine.

Authors:  Sicheng Wang; He Yu; Jianping Liu; Baoyan Liu
Journal:  Front Med       Date:  2011-06-22       Impact factor: 4.592

3.  Diagnosis and treatment of malignant tumors using integrated traditional and western medicine: progress, challenges and reflections.

Authors:  Xiao-feng Zhai; Chang-quan Ling
Journal:  Chin J Integr Med       Date:  2012-05-02       Impact factor: 1.978

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.